BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leelawat K, Narong S, Wannaprasert J, Ratanashu-ek T. Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma. World J Gastroenterol 2010; 16(37): 4697-4703 [PMID: 20872971 DOI: 10.3748/wjg.v16.i37.4697]
URL: https://www.wjgnet.com/1007-9327/full/v16/i37/4697.htm
Number Citing Articles
1
Wei Cheng, Yunlong Chen, Feng Yan, Lin Ding, Shijia Ding, Huangxian Ju, Yibing Yin. Ultrasensitive scanometric strategy for detection of matrix metalloproteinases using a histidine tagged peptide–Au nanoparticle probeChemical Communications 2011; 47(10): 2877 doi: 10.1039/c0cc04441e
2
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosisSurgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
3
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies2021; : 1 doi: 10.1007/978-3-030-37482-2_15-1
4
Chencheng Xie, Khalil Aloreidi, Bhavesh Patel, Timothy Ridgway, Thavam Thambi-Pillai, Gary Timmerman, Adeel Khan, Muslim Atiq. Indeterminate biliary strictures: a simplified approachExpert Review of Gastroenterology & Hepatology 2018; 12(2): 189 doi: 10.1080/17474124.2018.1391090
5
Tatsuki Mizuochi, Ken-ichiro Konishi. Introduction to Biliary Atresia2021; : 107 doi: 10.1007/978-981-16-2160-4_17
6
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already KnowCancers 2022; 14(6): 1493 doi: 10.3390/cancers14061493
7
Hiroaki Haga, Tushar Patel. Molecular diagnosis of intrahepatic cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 114 doi: 10.1002/jhbp.156
8
Hong Jin Yoon, Sung Ill Jang, Dong Ki Lee. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases2020; : 127 doi: 10.1007/978-981-13-0608-2_9
9
Bin Wang, Liang Chen, Hao-Teng Chang. Potential Diagnostic and Prognostic Biomarkers for Cholangiocarcinoma in Serum and BileBiomarkers in Medicine 2016; 10(6): 613 doi: 10.2217/bmm-2015-0062
10
PHANTHAKARN TIT-OON, DARANEE CHOKCHAICHAMNANKIT, AMNART KHONGMANEE, PHANEE SAWANGAREETRAKUL, JISNUSON SVASTI, CHANTRAGAN SRISOMSAP. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional cultureInternational Journal of Oncology 2014; 45(5): 2108 doi: 10.3892/ijo.2014.2636
11
Ravinnipa Chanakankun, Tanakorn Proungvitaya, Daraporn Chua‑On, Temduang Limpaiboon, Sittiruk Roytrakul, Apinya Jusakul, Attapol Titapun, Apiwat Jarearnrat, Siriporn Proungvitaya. Serum coiled‑coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinomaOncology Letters 2019;  doi: 10.3892/ol.2019.11162
12
Chatmanee Lertudomphonwanit, Reena Mourya, Lin Fei, Yue Zhang, Sridevi Gutta, Li Yang, Kevin E. Bove, Pranavkumar Shivakumar, Jorge A. Bezerra. Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresiaScience Translational Medicine 2017; 9(417) doi: 10.1126/scitranslmed.aan8462
13
Sven H. Loosen, Mihael Vucur, Christian Trautwein, Christoph Roderburg, Tom Luedde. Circulating Biomarkers for CholangiocarcinomaDigestive Diseases 2018; 36(4): 281 doi: 10.1159/000488342
14
Xiang-de Shi, Xian-huan Yu, Wen-rui Wu, Xiao-lin Xu, Jie-Yu Wang, Lei-bo Xu, Rui Zhang, Chao Liu. Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinomaOncotarget 2016; 7(43): 70378 doi: 10.18632/oncotarget.11859
15
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies2022; : 237 doi: 10.1007/978-3-030-41683-6_15
16
Sven A. Lang, Jan Bednarsch, Katharina Joechle, Iakovos Amygdalos, Zoltan Czigany, Lara Heij, Tom F. Ulmer, Ulf P. Neumann. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the artExpert Review of Gastroenterology & Hepatology 2021; 15(5): 497 doi: 10.1080/17474124.2021.1912591
17
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinomaNature Reviews Gastroenterology & Hepatology 2012; 9(1): 44 doi: 10.1038/nrgastro.2011.222
18
Christopher L. Bowlus, Kristin A. Olson, M. Eric Gershwin. Evaluation of indeterminate biliary stricturesNature Reviews Gastroenterology & Hepatology 2016; 13(1): 28 doi: 10.1038/nrgastro.2015.182
19
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on BileCurrent Topics in Medicinal Chemistry 2024; 24(8): 722 doi: 10.2174/0115680266290367240130054142
20
Si-Young Kim, Hee-Seung Lee, Seung-Min Bang, Dai-Hoon Han, Ho-Kyoung Hwang, Gi-Hong Choi, Moon-Jae Chung, Seung-Up Kim. Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic CholangiocarcinomaCancers 2021; 13(8): 1828 doi: 10.3390/cancers13081828
21
Alan Brijbassie, Paul Yeaton. Approach to the patient with a biliary strictureTechniques in Gastrointestinal Endoscopy 2016; 18(2): 44 doi: 10.1016/j.tgie.2016.05.001
22
Peter Findeisen, Michael Neumaier. Functional protease profiling for diagnosis of malignant diseasePROTEOMICS – Clinical Applications 2012; 6(1-2): 60 doi: 10.1002/prca.201100058
23
Lavinia-Patricia Mocan, Maria Ilieș, Carmen Stanca Melincovici, Mihaela Spârchez, Rareș Crăciun, Iuliana Nenu, Adelina Horhat, Cristian Tefas, Zeno Spârchez, Cristina Adela Iuga, Tudor Mocan, Carmen Mihaela Mihu. Novel approaches in search for biomarkers of cholangiocarcinomaWorld Journal of Gastroenterology 2022; 28(15): 1508-1525 doi: 10.3748/wjg.v28.i15.1508
24
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e2024; : 291 doi: 10.1002/9781119756422.ch17
25
Yuan Shi, Xiaxing Deng, Qian Zhan, Baiyong Shen, Xiaolong Jin, Zhecheng Zhu, Hao Chen, Hongwei Li, Chenghong Peng. A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of CholangiocarcinomaJournal of Gastrointestinal Surgery 2013; 17(9): 1584 doi: 10.1007/s11605-013-2182-9
26
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
27
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a reviewBiomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
28
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinomaLiver International 2019; 39(S1): 108 doi: 10.1111/liv.14090
29
Atsushi Matsuda, Atsushi Kuno, Hideki Matsuzaki, Toru Kawamoto, Toshihide Shikanai, Yasuni Nakanuma, Masakazu Yamamoto, Nobuhiro Ohkohchi, Yuzuru Ikehara, Junichi Shoda, Jun Hirabayashi, Hisashi Narimatsu. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinomaJournal of Proteomics 2013; 85: 1 doi: 10.1016/j.jprot.2013.04.017
30
Teijiro Hirashita, Yukio Iwashita, Masayuki Ohta, Yoko Komori, Hidetoshi Eguchi, Kazuhiro Yada, Seigo Kitano. Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic CholangiocarcinomaJournal of Gastrointestinal Surgery 2012; 16(4): 842 doi: 10.1007/s11605-011-1813-2
31
A. Singh, A. Gelrud, B. Agarwal. Biliary strictures: diagnostic considerations and approachGastroenterology Report 2015; 3(1): 22 doi: 10.1093/gastro/gou072
32
Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott, Sharon M. Weber. Intrahepatic Cholangiocarcinoma2019; : 11 doi: 10.1007/978-3-030-22258-1_2
33
Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, Domingo C. Balderramo, Juan W. Valle, Jesus M. Banales. Next-Generation Biomarkers for CholangiocarcinomaCancers 2021; 13(13): 3222 doi: 10.3390/cancers13133222
34
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bohyun Kim, Seong-Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji Hae Nahm, Won Suk Park, Eunkyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoungbun Lee, Dong Ho Lee, Myung Ah Lee, Seung Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Yong Eun Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon Seong Park. Practice guidelines for managing extrahepatic biliary tract cancersAnnals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 161 doi: 10.14701/ahbps.23-170
35
Natalia Calanzani, Paige E. Druce, Claudia Snudden, Kristi M. Milley, Rachel Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martinez-Gutierrez, Jasmeen Oberoi, Garth Funston, Mike Messenger, Jon Emery, Fiona M. Walter. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic ReviewAdvances in Therapy 2021; 38(2): 793 doi: 10.1007/s12325-020-01571-z
36
Charilaos Papafragkakis, Jeffrey Lee. Comprehensive management of cholangiocarcinoma: Part I. DiagnosisInternational Journal of Gastrointestinal Intervention 2017; 6(2): 85 doi: 10.18528/gii1500341
37
Richard Tang, Nicholas Latchana, Amir A. Rahnemai-Azar, Timothy M. Pawlik. Primary and Metastatic Liver Tumors2018; : 99 doi: 10.1007/978-3-319-91977-5_8
38
Sang-Hoon Lee, Si Young Song. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular ClassificationsCancers 2024; 16(9): 1761 doi: 10.3390/cancers16091761
39
Mustafa Gunes, Ahu Serap Kemik, Necip Pirincci, Ilhan Gecit, Kerem Taken, Mehmet Bilgehan Yuksel, Mehmet Kaba, Recep Eryilmaz. Preoperative Levels of Matrix Metalloproteinase-7 and -9 and Tissue Inhibitor of Matrix Metalloproteinase-1 Relation to Pathologic Parameters in Bladder Carcinoma PatientsAsian Pacific Journal of Cancer Prevention 2013; 14(2): 873 doi: 10.7314/APJCP.2013.14.2.873
40
ELISA PAOLICCHI, PAOLA PACETTI, ELISA GIOVANNETTI, ANDREA MAMBRINI, MASSIMO ORLANDI, FRANCESCO CREA, ANTONELLO A. ROMANI, ROBERTA TARTARINI, ROMANO DANESI, GODEFRIDUS J. PETERS, MAURIZIO CANTORE. A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinomaOncology Letters 2013; 6(5): 1487 doi: 10.3892/ol.2013.1559
41
Majda Haznadar, Christopher M. Diehl, Amelia L. Parker, Kristopher W. Krausz, Elise D. Bowman, Siritida Rabibhadana, Marshonna Forgues, Vajarabhongsa Bhudhisawasdi, Frank J. Gonzalez, Chulabhorn Mahidol, Anuradha Budhu, Xin W. Wang, Mathuros Ruchirawat, Curtis C. Harris. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic CholangiocarcinomaCancer Epidemiology, Biomarkers & Prevention 2019; 28(10): 1704 doi: 10.1158/1055-9965.EPI-19-0453
42
XIAOJUN ZENG, HUALIN TAO. Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)Oncology Letters 2015; 9(1): 3 doi: 10.3892/ol.2014.2696
43
Rocio I.R. Macias, Hiroaki Kanzaki, Carmen Berasain, Matias A. Avila, Jose J.G. Marin, Yujin Hoshida. The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic SignificanceThe American Journal of Pathology 2024;  doi: 10.1016/j.ajpath.2024.06.013
44
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2International Journal of Clinical Oncology 2024; 29(5): 512 doi: 10.1007/s10147-024-02497-0
45
Sam C. Wang, Justin R. Parekh, Matthew R. Porembka, Hari Nathan, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, T. Peter Kingham, William R. Jarnagin, Peter J. Allen. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma PatientsJournal of Gastrointestinal Surgery 2016; 20(5): 899 doi: 10.1007/s11605-015-3057-z
46
Bo Tang, Jian Du, Yang Li, Fang Tang, Zhenran Wang, Songqing He. EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0271-6
47
Barbara Maria Piskór, Andrzej Przylipiak, Emilia Dąbrowska, Iwona Sidorkiewicz, Marek Niczyporuk, Maciej Szmitkowski, Sławomir Ławicki. Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast CancerJournal of Clinical Medicine 2021; 10(7): 1436 doi: 10.3390/jcm10071436